NCT06031246View on ClinicalTrials.gov

Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)

PHASE3RecruitingINTERVENTIONAL
Enrollment

634

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

January 1, 2026

Study Completion Date

December 31, 2030

Conditions
Lung AdenocarcinomaLymph Node Metastasis
Interventions
PROCEDURE

Selective Lymph Node Dissection

For patients with NSCLC with CTR\>0.5 located in the apical segment, the inferior mediastinal lymph node was not need to dissected

Trial Locations (1)

200032

RECRUITING

Chaoqiang Deng, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER